Trifecta Capital Advisors »

Revolution Medicines shares owned by Trifecta Capital Advisors

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Trifecta Capital Advisors from 13F filings

Historical chart of Trifecta Capital Advisors investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Trifecta Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Trifecta Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $188 1 188.00

More positions owned by Trifecta Capital Advisors

Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Caterpillar (CAT)
Ishares Tr Core S&p Mcp Etf (IJH)
Palo Alto Networks (PANW)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Advanced Micro Devices (AMD)
Crowdstrike Hldgs Cl A (CRWD)

View all positions for Trifecta Capital Advisors

Top funds holding Revolution Medicines

BlackRock
Farallon Capital Management
FMR
Baker Bros. Advisors
Jupiter Topco
Darwin Global Management
Henderson Group
Vanguard Capital Management
Vanguard Portfolio Management
Nextech Invest
Paradigm Biocapital Advisors
UBS Group
State Street Corporation
Geode Capital Management
Wellington Management Company

View all funds holding Revolution Medicines